Rithm Capital
RITM
$8.62
+1.06%
Rithm Capital Corp. is a real estate investment trust that provides capital and services across the real estate and financial services industries, operating through four segments: Origination and Servicing, Investment Portfolio, Residential Transitional Lending, and Asset Management. Its portfolio centers on mortgage servicing rights (full and excess MSRs and servicer advances), residential securities and associated call rights, single-family rental and consumer loans, positioning it as a hybrid mortgage REIT and fee-based asset manager rather than a pure spread-lending vehicle. The current investor debate hinges on whether Rithm's transformation into a diversified, fee-generating mortgage platform can offset the earnings volatility embedded in its MSR-heavy balance sheet, particularly after a Q4 2025 print that showed revenue up 52.6% year-over-year but net income collapsing to $85 million from $290 million a year earlier. With shares down roughly 21% over the past year and trading at a deep discount to book value, the market is effectively questioning the durability of book value and the sustainability of the company's 10.4% dividend yield, even as management continues to expand asset management and origination capabilities.…
RITM
Rithm Capital
$8.62
Investment Opinion: Should I buy RITM Today?
The synthesized recommendation is Hold. The core thesis is that Rithm's deep discount to book value (0.73x) and extremely low forward PE (3.88x) offer compelling value, but the collapse in net income (down 70.7% year-over-year) and heavy debt load (4.69x debt-to-equity) create too much uncertainty to justify a Buy at this time. The analyst consensus average target of $13.15 implies 44% upside, but the market's persistent skepticism suggests the burden of proof is on upcoming earnings.
Supporting evidence for a Hold includes: the 0.73x price-to-book, which is near the bottom of its historical range; the 3.88x forward PE based on the consensus EPS estimate of $2.45; the 52.6% year-over-year revenue growth in Q4 2025; and the 10.45% dividend yield with a 94.4% payout ratio. However, these positives are offset by the 5.11% net margin in Q4 2025, the 4.69x debt-to-equity, and the volatile free cash flow. The stock's 21.29% one-year decline and 38.51 percentage point underperformance versus SPY highlight the market's lack of confidence.
The biggest risks that could invalidate the thesis are a further decline in net income, a dividend cut, or a breach of the 52-week low of $8.43. This Hold would upgrade to Buy if the company demonstrates sustained earnings recovery (e.g., quarterly EPS above $0.50) or if the price-to-book ratio falls below 0.65x, offering a wider margin of safety. It would downgrade to Sell if revenue growth decelerates below 10% or if the dividend is cut. Relative to its history and peers, Rithm appears undervalued on a price-to-book basis, but the market is pricing in significant risks that need to be resolved.
Sign up to view all
RITM 12-Month Price Forecast
The forward-looking view is cautiously neutral. Rithm's valuation is undeniably cheap, with a 0.73x price-to-book and a 3.88x forward PE, but the earnings collapse and heavy debt load create significant uncertainty. The analyst consensus is uniformly bullish, but the market's persistent skepticism suggests the burden of proof is on upcoming earnings. I would upgrade to bullish if the company reports two consecutive quarters of EPS above $0.50 and maintains its dividend, or if the price-to-book ratio falls below 0.65x. I would downgrade to bearish if the dividend is cut or if net income fails to recover above $150 million per quarter.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Rithm Capital's 12-month outlook, with a consensus price target around $13.10 and implied upside of +52.0% versus the current price.
Average Target
$13.10
0 analysts
Implied Upside
+52.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$13 - $14
Analyst target range
Coverage is solid with 10 analysts, and the sentiment is uniformly constructive: the consensus average target price is $13.15, implying +44.0% upside from the current $9.13 price. The target range is $12.50 to $14.00, meaning even the lowest analyst target implies +36.9% upside and the highest implies +53.3% — an unusually tight, uniformly bullish spread. Institutional ratings corroborate this: Piper Sandler reiterated Overweight on February 4, 2026, Jones Trading reiterated Buy on October 30, 2025, and BTIG, UBS, RBC Capital, Keefe Bruyette & Woods, and Wedbush have all maintained Buy or Outperform ratings over the past year with no downgrades in the dataset. The consensus is unambiguously bullish, and the complete absence of Hold or Sell ratings is notable.
The tight $1.50 target spread signals high conviction among analysts, but it also creates a stark disconnect with the market: the stock is down 21.29% over the past year while every covering analyst maintains a Buy-equivalent rating and a target at least 37% above the current price. The high target of $14.00 would require the shares to reclaim and exceed the 52-week high of $12.15, implying multiple expansion back toward book value plus delivery on the $2.45 consensus EPS estimate; the low target of $12.50 still assumes a 37% re-rating. This divergence suggests either that analysts are anchored to book value and normalized earnings power that the market no longer believes in, or that the market is mispricing a genuine value opportunity. Given the elevated short ratio of 6.52 days-to-cover and the persistent relative underperformance, the burden of proof rests on upcoming earnings to validate the analyst community's optimism.
Drowning in data?
Find the real signal!
Bulls vs Bears: RITM Investment Factors
The bear case currently has stronger evidence, driven by the collapse in net income (down 70.7% year-over-year), the heavy debt load (4.69x debt-to-equity), and the stock's severe underperformance (-21.29% over one year). However, the bull case rests on a compelling valuation disconnect: a 0.73x price-to-book and a 3.88x forward PE imply the market is pricing in a worst-case scenario that may not materialize. The single most important tension is whether Rithm can deliver on the consensus EPS estimate of $2.45; if it does, the stock is deeply undervalued, but if earnings disappoint, the trailing PE of 10.38x and the 94.4% payout ratio become the reality. Analyst consensus is uniformly bullish with a $13.15 average target, but the market's persistent skepticism suggests the burden of proof is on upcoming earnings to validate that optimism.
Bullish
- Deep discount to book value: RITM trades at a price-to-book ratio of 0.73x, meaning the market values the company at a 27% discount to its stated book value. For a mortgage REIT, this is a historically wide gap, and a re-rating toward 1.0x book would imply a share price of roughly $12.50, aligning with the lowest analyst target.
- Extreme forward PE compression: The trailing PE of 10.38x collapses to a forward PE of just 3.88x based on the consensus EPS estimate of $2.45. This implies the market expects earnings to more than triple, and if Rithm delivers even close to that estimate, the stock is priced at a fraction of normalized earnings power.
- Strong revenue growth and margins: Q4 2025 revenue surged 52.6% year-over-year to $1.663 billion, with gross margin at 90.95% and operating margin at 44.56%. The sequential revenue path through 2025 ($1.322B, $1.234B, $1.334B, $1.663B) shows a clear upward inflection into year-end.
- Uniformly bullish analyst consensus: All 10 covering analysts maintain Buy-equivalent ratings with an average target of $13.15, implying 44% upside. The target range of $12.50 to $14.00 is unusually tight, signaling high conviction, and even the lowest target implies 36.9% upside from the current $9.13 price.
Bearish
- Collapsing net income and margins: Q4 2025 net income fell to $85.0 million from $290.2 million a year earlier, a 70.7% decline, with net margin compressing to 5.11% from 26.62%. EPS dropped to $0.09 from $0.51, and the trailing twelve-month EPS of $0.11 is far below what a leveraged mortgage REIT should generate.
- Heavy debt load and thin coverage: Debt-to-equity stands at 4.69x with a total debt-to-capitalization of 82.46%, leaving the company highly dependent on external financing. Interest coverage is roughly 1.47x, and interest expense of $440 million consumed a large portion of operating income in Q4 2025.
- Severe relative underperformance: RITM is down 21.29% over the past year and 16.85% year-to-date, underperforming SPY by 38.51 and 29.96 percentage points respectively. The stock sits just 20.4% above its 52-week low of $8.43 and 24.9% below its 52-week high of $12.15, signaling persistent distribution.
- Volatile and negative free cash flow: Free cash flow swung from +$1.177 billion in Q4 2025 to -$2.042 billion in Q3 2025 and -$557 million in Q2 2025, reflecting the mark-to-market and investment-purchase churn inherent to the model. This volatility undermines the reliability of the dividend and book value.
RITM Technical Analysis
Rithm is in a sustained downtrend, with the shares down 21.29% over the past twelve months and 16.85% year-to-date, badly lagging the S&P 500's +17.22% and +13.11% over the same periods. At $9.13, the stock sits just 20.4% above its 52-week low of $8.43 and 24.9% below its 52-week high of $12.15, placing it in the lower quartile of its annual range. That positioning signals persistent distribution rather than a basing pattern, and the relative strength line confirms the damage: RITM has underperformed SPY by 38.51 percentage points over one year and 29.96 points year-to-date, meaning capital has been actively rotating out of this name rather than merely treading water.
Short-term momentum has deteriorated sharply and is diverging negatively from the already-weak longer-term trend. The stock is down 9.42% over the past month versus a +0.69% gain for SPY, a 10.11-point relative shortfall, and down 2.67% over three months against SPY's +5.81%. The most recent price action is telling: after rallying from $8.98 on July 23 to a local peak of $10.38 on August 19, the shares have given back nearly all of that move, closing at $9.13 on September 25 and printing a fresh recent low of $9.12 on September 24. This failure at the $10.25-$10.38 zone on multiple attempts (August 4, August 11-14, August 19) confirms that level as supply, and the accelerating decline into late September suggests momentum is decelerating rather than stabilizing.
Key technical levels are now clearly defined. Support rests at the 52-week low of $8.43, roughly 7.7% below the current $9.13 price; a breakdown there would open the door to a new leg lower and likely trigger further momentum selling given the elevated short ratio of 6.52 days-to-cover. Resistance is layered at $10.25-$10.38 (the August rejection zone) and then the 52-week high of $12.15, which would require a 33.1% rally to reclaim. With a beta of 1.113, Rithm is about 11% more volatile than the market, and its maximum drawdown of -30.51% over the measured period underscores that position sizing should account for meaningful downside beta; the current 9.42% one-month decline against a flat market is a textbook example of that amplified sensitivity.
Beta
1.16
1.16x market volatility
Max Drawdown
-32.4%
Largest decline past year
52-Week Range
$8-$12
Price range past year
Annual Return
-21.3%
Cumulative gain past year
| Period | RITM Return | S&P 500 |
|---|---|---|
| 1m | -13.4% | +1.0% |
| 3m | -6.1% | +2.5% |
| 6m | -13.3% | +13.9% |
| 1y | -21.3% | +15.0% |
| ytd | -21.5% | +13.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RITM Fundamental Analysis
Rithm's revenue trajectory is growing but highly uneven. Q4 2025 revenue of $1.663 billion rose 52.59% year-over-year from $1.090 billion in Q4 2024, and the sequential path through 2025 was $1.322 billion (Q1), $1.234 billion (Q2), $1.334 billion (Q3), and $1.663 billion (Q4) — a clear upward inflection into year-end. However, the composition matters: interest revenue of $942 million and asset management revenue of $447 million dominate the mix, with only $129 million from other product and service revenue, meaning the top line remains heavily levered to rate-sensitive spread income rather than recurring fee streams. The Q4 revenue surge did not translate into earnings power, which raises the question of whether growth is being purchased through balance-sheet expansion rather than earned through improving unit economics.
Profitability is the central concern. Q4 2025 net income of $85.0 million equates to a net margin of just 5.11%, down sharply from 26.62% in Q4 2024 and 16.61% in Q3 2025, despite a gross margin of 90.95% and an operating margin of 44.56%. The culprit is visible in the income statement: interest expense of $440 million and other expenses of $866 million consumed the bulk of a $646 million operating income line, leaving pre-tax income of only $206 million and a 56.1% effective tax rate that further compressed the bottom line. EPS of $0.09 in Q4 2025 versus $0.51 in Q4 2024 illustrates the compression vividly; the trailing twelve-month EPS of $0.11 and ROE of 8.08% are well below what a mortgage REIT with this leverage profile should generate in a normalized environment.
The balance sheet is the key risk. Debt-to-equity stands at 4.69x, with a debt ratio of 74.66% and total debt-to-capitalization of 82.46%, leaving the company highly dependent on external financing — evidenced by $581.6 million of common stock issued in Q4 2025 and $290.7 million in Q3 2025. Free cash flow is wildly volatile: +$1.177 billion in Q4 2025, -$2.042 billion in Q3 2025, -$557 million in Q2 2025, and +$1.421 billion in Q1 2025, reflecting the mark-to-market and investment-purchase churn inherent to the model. Positively, the current ratio of 1.79 and cash balance of $2.789 billion provide near-term liquidity, and the dividend payout ratio of 94.4% is technically covered by earnings, but with ROA of just 1.01% and interest coverage of roughly 1.47x, the margin for error is thin if funding costs rise or MSR valuations decline.
Quarterly Revenue
$1.3B
2026-06
Revenue YoY Growth
+3.9%
YoY Comparison
Gross Margin
63.8%
Latest Quarter
Free Cash Flow
$-1.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RITM Overvalued?
Because Rithm is profitable — trailing net income is positive with EPS of $0.11 — the PE ratio is the appropriate primary metric, though the low earnings base makes it noisy. The trailing PE of 10.38x compares to a forward PE of just 3.88x, an extraordinarily wide gap that implies the market expects earnings to roughly triple, consistent with the analyst consensus EPS estimate of $2.45 for the forward period. That gap is the entire bull case in one number: if Rithm delivers anywhere near $2.45 in EPS, the stock at $9.13 is priced at under 4x forward earnings, which would be deeply undervalued; if earnings disappoint, the trailing multiple is the reality.
On peer-relative grounds, the picture is mixed. The price-to-book ratio of 0.73x is the most informative metric for a mortgage REIT, and it indicates the market values Rithm at a 27% discount to its stated book value — a meaningful discount to the ~1.0x book at which well-run agency mREITs typically trade, though not unusual for hybrid REITs with credit exposure. The price-to-sales ratio of 1.08x and EV/EBITDA of 32.4x tell conflicting stories: the low PS ratio reflects the large interest-income component of revenue, while the elevated EV/EBITDA reflects the heavy debt load embedded in enterprise value. The 10.45% dividend yield is roughly four times the sector norm, which the market is clearly treating as a distress signal rather than an income opportunity.
Historically, Rithm's valuation sits near the low end of its own range. The PE ratio has ranged from 4.65x (Q1 2024) to 23.74x (Q1 2025) over the past two years, and the current 10.38x is in the middle of that band but well above the 4.8x-5.5x troughs seen in mid-2024 and mid-2025. More tellingly, the price-to-book ratio of 0.73x is near the bottom of its historical range — it traded at 0.84x in Q1 2021, 0.77x in Q1 2025, and 0.72x-0.73x in recent quarters — suggesting the market has consistently refused to pay book value for this franchise. The combination of a mid-range PE and a bottom-of-range PB implies the market is pricing in either book value erosion or a permanent discount for complexity and leverage.
PE
10.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 2x~30x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
32.4x
Enterprise Value Multiple
Investment Risk Disclosure
Rithm's financial and operational risks are substantial. The company carries a debt-to-equity ratio of 4.69x and a total debt-to-capitalization of 82.46%, leaving it highly dependent on external financing; it issued $581.6 million of common stock in Q4 2025 alone. Interest coverage is thin at roughly 1.47x, and interest expense of $440 million consumed a significant portion of operating income. Net income collapsed to $85.0 million in Q4 2025 from $290.2 million a year earlier, with net margin falling to 5.11% from 26.62%, and free cash flow is wildly volatile, swinging from +$1.177 billion in Q4 2025 to -$2.042 billion in Q3 2025. The dividend payout ratio of 94.4% leaves little margin for error if earnings decline further.
Market and competitive risks are equally concerning. The stock trades at a 0.73x price-to-book, near the bottom of its historical range, reflecting persistent market skepticism about book value durability. With a beta of 1.113, Rithm is about 11% more volatile than the market, and its 9.42% one-month decline against a flat market exemplifies this amplified sensitivity. The 10.45% dividend yield is roughly four times the sector norm, which the market is treating as a distress signal. Competitive pressures in mortgage servicing and asset management could compress spreads, and any deterioration in MSR valuations would directly hit the balance sheet. The complete absence of Hold or Sell ratings among analysts creates a consensus that may be slow to adjust if fundamentals worsen.
In a worst-case scenario, a combination of rising funding costs, MSR valuation declines, and a earnings miss could trigger a sharp sell-off. The 52-week low of $8.43 represents a 7.7% decline from the current $9.13 price, and a breakdown below that level could open the door to a new leg lower, especially with a short ratio of 6.52 days-to-cover. The maximum drawdown over the measured period is -30.51%, implying a potential decline to roughly $6.34 from the current price in a severe adverse scenario. If the company cuts its dividend or reports another quarter of collapsing net income, the stock could easily retest or breach its 52-week low, resulting in a loss of 7.7% to 30.5% from current levels.
FAQ
The most severe risk is financial: the company's net income fell 70.7% year-over-year in Q4 2025, and its debt-to-equity of 4.69x leaves it vulnerable to rising funding costs. Second, there is a dividend risk: the payout ratio is 94.4%, and any earnings decline could force a cut, which would likely trigger a sharp sell-off given the 10.45% yield. Third, market risk: with a beta of 1.113, RITM is more volatile than the market, and it has underperformed SPY by 38.51 percentage points over the past year. Fourth, competitive and regulatory risks in the mortgage servicing industry could compress margins.
The 12-month forecast is neutral with a slight bullish bias. The base case (55% probability) targets a range of $10.50 to $12.50, assuming moderate earnings recovery and stable interest rates. The bull case (25% probability) targets $12.50 to $14.00, driven by an earnings beat and a re-rating toward book value. The bear case (20% probability) targets $8.43 to $9.50, reflecting an earnings miss or dividend cut. The most likely scenario is the base case, with the key assumption that net income stabilizes at $150-$200 million per quarter.
RITM appears undervalued on a price-to-book basis, trading at 0.73x compared to the ~1.0x book value at which well-run agency mREITs typically trade. The forward PE of 3.88x is extremely low, implying the market expects earnings to triple from trailing levels. However, the trailing PE of 10.38x is in the middle of its two-year range (4.65x to 23.74x), and the price-to-book is near the bottom of its historical range. The market is pricing in significant risks, including book value erosion and leverage, which may be overdone if earnings recover.
RITM presents a high-risk, high-reward opportunity. The stock trades at a 0.73x price-to-book and a 3.88x forward PE, with analysts projecting 44% upside to their average target of $13.15. However, the company's net income collapsed 70.7% year-over-year in Q4 2025, and its 4.69x debt-to-equity ratio raises concerns about financial stability. The 10.45% dividend yield is attractive but may be at risk if earnings do not recover. For investors with a high risk tolerance and a long time horizon, RITM could be a value play, but it is not suitable for conservative portfolios.
RITM is better suited for long-term investors who can tolerate volatility and are attracted to the high dividend yield. The stock's beta of 1.113 and maximum drawdown of -30.51% make it unsuitable for short-term trading unless one is actively hedging. The company's earnings visibility is low, with volatile free cash flow and a complex business model. A minimum holding period of 2-3 years is recommended to allow for the earnings recovery and potential re-rating to book value. Short-term traders should be aware of the elevated short ratio of 6.52 days-to-cover, which can amplify moves.
